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Inﬂammatory arthropathiesSeaweed lectins have been widely investigated as anti-nociceptive and anti-inﬂammatory agents. This study
analyzed the anti-nociceptive and anti-inﬂammatory responses of a lectin from the green seaweed Caulerpa
cupressoides (CcL) on zymosan-induced arthritis of the rat temporomandibular joint (TMJ). Rats received i.v.
CcL 30 min prior to injection of zymosan (2 mg/art.) or 0.9% saline into the left TMJ. Mechanical hyper-
nociception was measured by the electronic von Frey method at baseline and 4 h after zymosan injection.
Animals were euthanized 6 h after zymosan injection and the synovial ﬂuidwas collected for leukocyte counting
and myeloperoxidase activity assessment. Other animals were treated with ZnPP-IX (3 mg/kg; s.c.), a speciﬁc
heme oxygenase-1 pathway inhibitor, and naloxone (10 μg/art.), a nonselective opioid receptor antagonist.
TMJ tissues were excised to perform histopathological and immunohistochemistry analyses. CcL (0.1, 1 or
10 mg/kg) signiﬁcantly reduced zymosan-induced hyper-nociception (81, 83 and 89.5%, respectively) and
inhibited the leukocyte inﬂux (77.3, 80.7 and 98.5%, respectively) compared with the zymosan-only group, as
conﬁrmed by myeloperoxidase activity; however, treatment with naloxone or ZnPP-IX did not revert the effects
of CcL (10 mg/kg), suggesting that the naloxone-sensitive opioid and heme oxygenase-1 pathways are not
involved. CcL also reduced the leukocyte inﬂux and the expression of IL-1β and TNF-α in the TMJ, based on
histopathological and immunohistochemistry analyses, respectively. Therefore, CcL reduces TMJ hyper-
nociception and inﬂammation with a mechanism that is partially dependent on TNF-α and IL-1β inhibition.
CcL reveals a potentially valuable alternative tool for future studies of TMJ disorders.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Temporomandibular joint (TMJ) disorders are a group of conditions
that result in TMJ pain, which frequently limits talking, chewing, and
other basic daily activities with high levels of pain-related disability. To
clarify the underlying pathogenesis of temporomandibular disorder-
related inﬂammatory pain, we have developed a rat model of TMJ
inﬂammation using intra-articular injections of the pro-inﬂammatorydo Ceará, Departamento de
o Pici, CEP: 60440-900, Brazil.agent zymosan [1]. Zymosan is a polysaccharide from yeast cell walls
that produces a severe and erosive synovitis [2,3] associatedwith inﬂam-
matory pain in animal models of knee arthritis [4].
Increased levels of pro-inﬂammatory cytokines (IL-1β and TNF-α)
have been detected in patients with temporomandibular disorders
(TMD), suggesting that these cytokinesmay play a role in the pathogen-
esis of synovitis and degenerative changes of the cartilaginous tissue
and bone of the temporomandibular joint [5,6].
Heme oxygenase 1 (HO-1) plays an important role in the antioxi-
dant defense system, and its induction would provide a negative feed-
back for cell activation and the production of inﬂammatory mediators,
which could modulate, at least in part, the inﬂammatory pain process
[7–9]. A role for the endogenous opioid system in the phenomenon of
pain [10] and a role for the peripheral opioid receptors in TMJ anti-
nociception, are well-demonstrated [11,12].
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rate TMJ inﬂammation, although these drugs are associatedwith several
adverse effects (mainly gastrointestinal, cardiovascular and kidney tox-
icity) [13,14]. Therefore, there is a great need for scientiﬁc studies that
search for new bioactive compounds, such as those derived from plants,
with therapeutic action and that conﬁrmed efﬁcacy and safety [15–18].
Seaweeds have lectins, which are proteins or glycoproteins of non-
immune origin containing at least one non-catalytic domain that binds
reversibly to speciﬁc mono- or oligosaccharides [19]. The biotechnolog-
ical importance of these polymers has been described for various ﬁelds,
including biochemistry [20], agriculture [21] and, more recently, they
have been recognized as important tools to control nociception [22]
and inﬂammation [23]. However, to the best of our knowledge [1,24],
there are no studies about the use of lectins on experimental arthritis
of the rat TMJ.
Caulerpa cupressoides var. lycopodium C. Agardh is a species of green
seaweed belonging to the family Caulerpaceae and is widely found
along the coast of northeast Brazil. The isolated lectin from this
algal species (CcL) was previously puriﬁed and characterized by physi-
cochemical procedures that indicated a dimer (23–44 kDa) with
hemagglutinating activity containing glycine, aspartic acid, glutamic
acid, serine and a low content of basic amino acids. Furthermore, it
has been reported in the literature that this lectin can be inhibited by
derivatives of galactose and strongly inhibited by the glycoprotein
porcine stomachmucin, a glycoprotein with a terminal GalNAc residue,
and fucose and galactose as internal residues [25].
Our group demonstrated CcL anti-nociceptive and anti-inﬂammatory
effects in classical models of nociception and acute inﬂammation in vivo
[26], as well as immunomodulatory properties on cell viability in vitro,
inducing T helper 2 immune responses in mouse splenocytes and
producing high levels of IL-10 and IL-6 [27].
Therefore, we analyzed the unexplored anti-nociceptive and anti-
inﬂammatory efﬁcacy of CcL in a model of zymosan-induced TMJ in-
ﬂammatory hyper-nociception in the rat. Additionally, we investigated
the putative involvement of IL-1β, TNF-α, HO-1 and the endogenous
opioid system in CcL efﬁcacy.2. Materials and methods
2.1. Animals
Male Wistar rats (180–240 g) from the Animal Care Unit of the
Federal University of Ceará in Fortaleza, Brazil, were used throughout
the experiments. They were housed in a temperature-controlled room
with free access to water and food on a 12/12 h light/dark cycle. For
each experiment, groups of six animals were segregated and handled
separately. All procedures and animal treatments were carried out at
ambient temperature (20–22 °C), and special care was taken to avoid
environmental disturbances that might inﬂuence animal responses.
This study was conducted in accordance with the guidelines set forth
by the U.S. Department of Health and Human Services and with the
approval of the Ethics Committee of the Federal University of Ceará,
Fortaleza, Brazil (CEPA no. 59/13).2.2. Drugs and reagents
The following drugs and reagents were used: zymosan, Zinco
Protoporﬁrina-IX (ZnPP-IX), indomethacin, DEAE-cellulose, ο-dianisidine
dihydrochloride, potassium phosphate monobasic, and potassium
phosphate dibasic which were purchased from Sigma (St. Louis, MO,
USA); hematoxylin, eosin and ethylenediaminetetraacetic acid (EDTA)
were purchased from VETEC Química Farm. LTDA, SP (Brazil). The re-
agents and the lectin (CcL) were solubilized in 0.9% sterile NaCl (saline)
or ultrapure water. All chemicals were of analytical grade.2.3. Marine alga
The green seaweed C. cupressoides var. lycopodium (Caulerpaceae,
Bryopsidales) was collected from the Atlantic coast of Brazil (Pacheco
Beach, Caucaia, Ceará). After collection, the material was cleaned of epi-
phytes, washed with distilled water and stored at−20 °C until use. A
voucher specimen (no. 4977) was deposited in the Herbarium Prisco
Bezerra in the Department of Biological Sciences, Federal University of
Ceará, Brazil.
2.4. Erythrocytes
Blood samples were obtained from healthy adult New Zealand
albino rabbits and maintained in the Animal Care Unit of the Federal
University of Ceará, Fortaleza, Brazil.
2.5. Isolation of C. cupressoides lectin (CcL)
The CcL was obtained from the fresh algal tissue macerated in the
presence of liquid nitrogen [25], with some modiﬁcations that were
proposed by Vanderlei et al. [26]. Extraction of CcL was performed
with Tris–HCl 25 mM, pH 7.5, (TB) at a ratio of 1:4 (w/v, alga:TB).
After constant stirring for 4 h, the homogenate was ﬁltered through
nylon cloth and then centrifuged (6000 ×g, 30 min, 4 °C). The precipi-
tate was discarded and the resulting supernatant (crude extract) was
subjected to ion-exchange chromatography on a DEAE-cellulose col-
umn (1.0 × 27.5 cm), equilibrated and eluted with TB. After elution of
the unbound proteins and pigments, the adsorbed proteins were eluted
from the gel using TB containing 0.5 M NaCl. The fraction containing
hemagglutinating activity was pooled, dialyzed and freeze-dried.
2.6. Experimental protocols
2.6.1. Induction of TMJ arthritis
Thismethodwas based on Chaves et al. [1]. Thirtyminutes before in-
jection with zymosan, rats were pretreated (0.1 ml/100 g body weight)
with CcL (0.1, 1 or 10 mg/kg) by intravenous (i.v.) injection or 0.9% ster-
ile saline. Control animals (sham) received the same volume of sterile
saline. Rats were brieﬂy anesthetized with inhaled isoﬂurane and re-
ceived an intra-articular (i.art.) injection of zymosan (2 mg, 40 μl total
volume) dissolved in sterile saline into the left TMJ using a 30-gauge
needle and a 1 ml syringe. Sham animals received saline i.art.
Before the zymosan or saline injection, the TMJ skin regionwas care-
fully shaved, the posteroinferior border of the zygomatic arch was pal-
pated, and the needle was inserted inferior to this point and advanced
in a medial and anterior direction until the needle made contact with
the condyle. This contact was veriﬁed by moving the mandible, and
the puncture of the needle into the joint space was conﬁrmed by the
loss of resistance. The animals were euthanized under anesthesia at 6 h
after zymosan-induced arthritis and inﬂammatory parameters (total
cell count and myeloperoxidase assay activity) were evaluated.
2.6.2. Evaluation of mechanical hyper-nociception
Mechanical hyper-nociception in the rat TMJ was evaluated by
measuring the threshold intensity of force that, when applied to the
TMJ region,would elicit a reﬂex response in the animal (e.g., headwith-
drawal). The measurements consisted of a continuous force applied to
the TMJ area, performed by an examiner unaware of the treatments,
and using a digital device (Insight, Ribeirão Preto, SP, Brazil) that
consisted of a rigid ﬁlament linked to an electronic device that mea-
sured the response threshold in grams (g) when the ﬁlament was
applied to the surface of the tested region. The facial areas to be tested
around the TMJ were carefully shaved, and the animals were placed
into individual plastic cages 45 min before the beginning of the tests.
The animals were submitted to conditioning sessions, consisting
of head withdrawal threshold measurements, in the testing room for
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illumination intensity [28]. On the ﬁfth day, the basal force threshold
value was recorded (in triplicate) before injection of CcL (0.1, 1 or
10 mg/kg, i.v.), zymosan (2 mg/i.art., 40 μl), sterile saline (0.9% NaCl,
w/v, i.art.) or indomethacin (5 mg/kg bodyweight, s.c.) andwas record-
ed again after 4 h.
2.6.3. Collection of the TMJ synovial ﬂuid and cell counting
Six hours after zymosan injection (i.art.), the rats were euthanized
under anesthesia and exsanguinated. The superﬁcial tissues were dis-
sected, and the TMJ cavity was washed to collect the synovial ﬂuid by
a pumping-and-aspiration technique using 0.05 ml of EDTA in neutral
buffered PBS. This procedure was repeated twice. The total number of
white cells in the synovial lavage ﬂuid was counted using a Neubauer
chamber [1].
2.6.4. Determination of myeloperoxidase (MPO) activity
MPO is an enzyme found primarily in azurophilic granules within
neutrophils and has been used extensively as a biochemical marker of
granulocyte inﬁltration into various tissues. The extent of neutrophil
accumulation in the TMJ synovial ﬂuid was measured using an MPO
activity assay as previously described [29]. Brieﬂy, MPO activity was
determined by measuring the change in absorbance at 450 nm using
o-dianisidine dihydrochloride and 1% hydrogen peroxide. A unit of
MPO activity was deﬁned as the activity that required the conversion
of 1 μmol of hydrogen peroxide to water within 1 min at 22 °C. The
results are reported as MPO units/joint.
2.6.5. Histopathological analysis
Six hours after zymosan-induced arthritis, the rats were euthanized
and the TMJ was excised. The specimenswere ﬁxed in 10% neutral buff-
ered formalin for 24 h, demineralized in 10% EDTA (7% formic acid),
embedded in parafﬁn, and sectioned along the long axis of the TMJ. Sec-
tions of 5 μm, which included the condyle, articular cartilage, articular
disk, synovial membrane and periarticular tissue, were evaluated
under light microscopy. For the specimens processed for routine hema-
toxylin–eosin (H& E) staining, histological analysis was used to assign a
graded 0–4 score based on the cell inﬂux into the synovial membrane,
the periarticular tissue and the musculoskeletal tissue [1].
2.6.6. Evaluation of possible involvement of the opioid system
To assess the possible participation of the opioid system in the anti-
nociceptive response to CcL, rats were pre-treated with naloxone
(10 μg/art., 15 μl), 35 min before the injection with zymosan (2 mg/art.,
35 μl). Five minutes later, the animals received the CcL (10 mg/kg, i.v.),
morphine (1000 μg, 0.1 ml, s.c.) or 0.9% sterile saline. The mechanical
hyper-nociception responses to these treatments were recorded after 4
h of zymosan (2 mg/art., 35 μl) or sterile saline injected i.art. into the
left TMJ of the rats. When two drugs were injected in the same TMJ, the
total volume of injection was 50 μl [30].
2.6.7. Evaluation of possible involvement of the HO-1 pathway in
nociceptive and inﬂammatory responses
This assay was based on Freitas et al. [31], Vanderlei et al. [9] and
Grangeiro et al. [8]. Animals (n = 6 per group) were treated with ZnPP-
IX (3 mg/kg, s.c.), followed by administration of CcL (10 mg/kg, i.v.) 30
min later. Zymosan (2 mg/art., 40 μl) was injected after 1 h. Mechanical
hyper-nociception and cell number from the TMJ synovial lavage ﬂuid
were measured after 4 and 6 h following the stimulus, respectively.
MPO activity assessment was also performed to conﬁrm the data. The
results were expressed as in Sections 2.6.2, 2.6.3 and 2.6.4.
2.6.8. Immunohistochemistry for IL-1β, TNF-α and HO-1
Immunohistochemistry for IL-1β, TNF-α and HO-1 were performed
using the streptavidin–biotin (Labeled Streptavidin Biotin— LSAB)meth-
od in formalin-ﬁxed, parafﬁn-embedded tissue sections (4 μm thick),mounted on glass slides previously prepared with an organosilane-
based adhesive (3-aminopropyltriethoxysilane). Brieﬂy, it consisted of
the following steps: the sections went through 2 baths in xylol, each
lasting 10 min. After this, they were immersed in three passages of ab-
solute alcohol, then washed in running water, and immediately passed
through distilled water.
After antigen retrieval, endogenous peroxidase was blocked
(15 min) with 3% (v/v) hydrogen peroxide, and the sections were
washed in phosphate-buffered saline (PBS). Sections were incubated
overnight (4 °C) with a primary rabbit anti-TNF-α, IL-1β and HO-1
antibodies (ab13243, ABCAM®, England, UK), at a dilution of 1:200,
and afterwards washed with a phosphate buffered saline solution, PBS
(phosphate buffered saline).
The slides were incubated with a secondary antibody LSAB Kit
(DAKO®, Carpinteria, CA, EUA) for 10 min at ambient temperature.
The slides were then incubated with a biotinylated goat anti-rabbit an-
tibody diluted 1:400 in PBS-BSA. Afterwashing, the slideswere incubat-
ed with an avidin–biotin–horseradish peroxidase conjugate (Strep ABC
complex, VECTASTAIN ABC Reagent and peroxidase substrate solution)
for 30 min according to the VECTASTAIN protocol. IL-1β and TNF-α
were visualizedwith the chromogen 3,3-diaminobenzidine (DAB). Neg-
ative control sections were processed simultaneously as described
above but with the ﬁrst antibody being replaced by 5% PBS-BSA. None
of the negative controls showed IL-1β, TNF-α or HO-1 immunoreactiv-
ity. Counter-staining was performed with hematoxylin, and afterwards
the specimens were dehydrated in alcohol and diaphanized in xylol.
Positive values were assigned to all cells that exhibited brown staining
in the cytoplasm, irrespective of the staining intensity.
2.6.9. Statistical analysis
The data are presented as the mean ± standard errors (S.E.M.) for
six animals per group. Differences between the means were compared
using a one-way ANOVA followed by the Bonferroni test. In the histo-
pathological analysis of the TMJ, the Kruskal–Wallis test was used,
followed by Dunn's test to compare medians. Values of p b 0.05 were
considered to be statistically signiﬁcant.
3. Results
3.1. CcL reduces mechanical hyper-nociception, leukocyte cell count and
MPO activity on zymosan-induced TMJ acute arthritis in rats
The i.art. injection of zymosan (2 mg/art., 40 μl) elicited (pb 0.001) a
mechanical hyper-nociception response (58.4 ± 6.4 g) compared with
the sham group (118.8 ± 4 g) at 4 h after the inﬂammatory stimulus,
as measured by a clear decrease in the mechanical threshold for head
withdrawal. The i.v. treatment of rats with CcL (0.1, 1 or 10 mg/kg),
administered 30 min prior to zymosan into the rat left TMJ, caused a
reduction in mechanical hyper-nociception at all tested doses by 81%
(107.3 ± 4.4 g), 83% (108.5 ± 5 g) and 89.5% (112.5 ± 3.4 g), respec-
tively, (p b 0.001), as measured at 4 h after zymosan injection. Indo-
methacin (5 mg/kg, s.c.) also produced an anti-nociception effect of
69% (100 ± 8.5 g, p b 0.01) (Fig. 1A).
Additionally, the i.art. injection of zymosan into the rat left TMJ re-
sulted in a signiﬁcant increase in the number of polymorphonuclear
cells (19,500± 241 cells/mm3) from the TMJ synovial ﬂuid at 6 h, com-
pared to the sham group (31± 6 cells/mm3). Pretreatment of rats with
CcL (0.1, 1 or 10 mg/kg, i.v.) decreased (p b 0.001), in a dose-dependent
manner, the leukocyte cell count from the TMJ synovial lavage ﬂuid by
77.3% (4450 ± 808.5 cells/mm3), 80.7% (3750 ± 1233 cells/mm3) and
98.5% (295.5 ± 156 cells/mm3), respectively, in comparison with the
zymosan group (Fig. 1B). Indomethacin resulted in 90.7% (1800 ±
638 cells/mm3) inhibition (p b 0.001) of the leukocyte number in the
synovial ﬂuid. The MPO activity also decreased in the TMJ synovial
lavage ﬂuid at all doses tested by 63% (29.5 ± 9 U/joint ﬂuid), 92%
(10 ± 4.5 U/joint ﬂuid) and 98% (2.5 ± 1 U/joint ﬂuid), respectively
A B
C
Fig. 1. Effect of CcL onmechanical hyper-nociception (A), leukocyte inﬂux (B) andMPO activity (C) of zymosan (Zy)-induced TMJ arthritis (4 h post-injection). Zy (2 mg/art., 40 μl) or 0.9%
saline was injected i.art. into the left TMJ of the rats. Indomethacin (5 mg/kg) was given s.c. 1 h before stimulus. Animals received s.c. saline or CcL (0.1, 1 or 10 mg/kg, i.v.). Data
are expressed as the mean ± S.E.M. of six animals for each group (ANOVA, Bonferroni's test). ***p b 0.001 indicates signiﬁcant difference from the sham group. ###p b 0.001 indicates
a signiﬁcant difference from the Zy group. +++p b 0.001 indicates a signiﬁcant difference from the indomethacin group.
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s.c.) also showed anti-inﬂammatory effects (55.5%, 53.3 ± 2 cells/mm3,
p b 0.05).3.2. CcL reverses tissue alteration in the zymosan-inﬂamed TMJ as assessed
by H & E staining
Table 1 shows the scores attributed to TMJ histopathological analysis
and compares the values between the sham and zymosan groups.
Groups of animals were treated with zymosan (2 mg/art., 40 μl) and
CcL (10 mg/kg, i.v.). The sham group received injection (i.art.) of saline
in the same volume. TMJ tissues were ﬁxed, sectioned and stained with
H & E. A signiﬁcant (p b 0.05) increase in the inﬂammatory parameters
was observed in the zymosan group.
Six hours after zymosan-induced TMJ arthritis, an inﬂammatory cell
inﬂux was observed in the synovial membrane, the periarticular tissueTable 1
Histopathological analysis of TMJ on zymosan-induced arthritis: the effects of CcL (10 mg/kg, i
Groups Cell inﬂux in the synovial membrane Cell
Sham 0 (0–0) 0 (0
Zy 4 (3–4)⁎ 4 (3
CcL 0 (0–0)⁎⁎⁎ 1 (1
0 — uninjured; 1 — low injury; 2 —mild injury; 3 —moderate injury; 4 — severe injury.
⁎ p b 0.05 versus sham group (Kruskal–Wallis, Dunn's).
⁎⁎ p b 0.05 indicate signiﬁcant difference in relation to Zy group (Kruskal-Wallis, Dunn's).
⁎⁎⁎ p b 0.01 indicate signiﬁcant difference in relation to Zy group (Kruskal–Wallis, Dunn's).and the skeletal muscle tissue, compared to the sham group. The cell
type was predominantly neutrophils, which are known to characterize
acute inﬂammation. Edema was also observed in the synovium. Pre-
treatment with CcL (10 mg/kg, i.v.) reduced the cellular inﬁltrate and
edema in the synovial membrane, periarticular tissue (p b 0.01) and
skeletal muscle tissue (p b 0.05), when compared to the zymosan
group. The inﬂammatory processwas considered asmoderate to severe.
These data can be seen in the TMJ photomicrographs (Fig. 2).3.3. Naloxone does not block the anti-nociceptive effect of CcL
Rat pretreatment with naloxone (10 μg/art., 15 μl), 5 min before CcL
(10 mg/kg, i.v.), did not interfere the antinociceptive response of this
compound on zymosan-induced TMJ acute arthritis in rats. By contrast,
at this dose, naloxone blocked the antinociceptive action of morphine
(1000 μg, 0.1 ml, s.c.) in this model (Fig. 3)..v.).
inﬂux in the periarticular tissue Cell inﬂux in the muscular tissue
–0) 0 (0–0)
–4)⁎ 2 (2–3)⁎
–1)⁎⁎⁎ 0 (0–2)⁎⁎
Fig. 2. Histopathological analysis of zymosan-induced TMJ arthritis in rats. (A) TMJ photomicrographs from the sham group (40×). (B, C and D) Synovial membrane, periarticular tissue
and musculoskeletal tissue of the sham group without cell inﬂux (400×). (E) Photomicrographs of TMJ in the Zy group (2 mg/art., 40 μl) (40×). (F, G and H) Synovial membrane,
periarticular tissue andmusculoskeletal tissue of the zymosan groupwith intense cell inﬂux (400×). (I) Photomicrographs of the TMJwith CcL (10 mg/kg, i.v.) (40×). (J, L andM) Synovial
membrane periarticular tissue andmusculoskeletal tissue from the group treated with CcL without cell inﬂux (400×). C: condyle; AC: articular cartilage; AD: articular disk; SM: synovial
membrane; PAT: periarticular tissue; and MET: musculoskeletal tissue. H & E staining. Black arrows indicate neutrophils.
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through the HO-1 pathway
To investigate the possible role of the HO-1 pathway in the anti-
nociceptive and anti-inﬂammatory effects of CcL, the rats were
pretreated (s.c.)with ZnPP-IX (3 mg/kg),which is a speciﬁcHO-1 inhib-
itor, resulting in the inhibition of this pathway. It was observed that the
anti-nociceptive and anti-inﬂammatory effects of the CcL (10 mg/kg,
i.v.) on the zymosan-induced arthritis in the rat TMJ model were not
inhibited in thepresence of ZnPP-IX (Fig. 4A, B), a result thatwas further
conﬁrmed byMPO activitymeasurement and histopathological analysis
(Fig. 4C).Fig. 3. Evaluation of the possible involvement of endogenous opioids in the anti-
nociceptive effect of CcL on zymosan (Zy)-induced mechanical hyper-nociception and
TMJ arthritis in the rat. Zy (2 mg/art., 40 μl) or 0.9% saline was injected i.art. into the left
TMJ of the rats. Animals received s.c. saline or CcL (10 mg/kg, i.v.) with or without nalox-
one (10 μg/art.) and morphine (1000 μg, 0.1 μl, s.c.) with or without naloxone. Data are
expressed as the mean ± S.E.M. of six animals for each group (ANOVA, Bonferroni's
test). ***p b 0.01 indicates signiﬁcant difference from the sham group. ###p b 0.001
indicates signiﬁcant difference from the Zy group. +++p b 0.001 indicates signiﬁcant
difference from the group morphine. &&&p b 0.001 indicates signiﬁcant difference from
the morphine group with CcL.Table 2 shows the scores attributed to TMJs and compares the values
between the zymosan arthritic TMJ group, CcL (10 mg/kg, i.v.), speciﬁc
HO-1 inhibitor ZnPP-IX (3 mg/kg), and ZnPP-IX plus CcL. The histopath-
ological analyses showed that CcL reduced the inﬂammatory parame-
ters to a normal level with a low inﬂammatory cell inﬂux in the
periarticular tissue (p b 0.05), compared to the zymosan group. The in-
ﬂammatory process was consideredmoderate to severe for the synovial
membrane and periarticular tissue, and for the musculoskeletal tissue,
the inﬂammatory process was considered medium to moderate.
The group treated with ZnPP-IX maintained a moderate to severe
inﬂammatory response for the synovial membrane and periarticular
tissue, and a medium to moderate response for the musculoskeletal
tissue. The group treated with ZnPP-IX + CcL showed reduced inﬂam-
matory cell inﬂux in the synovial membrane and the periarticular tis-
sue; however, only the periarticular tissue was statistically signiﬁcant.
These data can be seen in the TMJ photomicrographs (Fig. 5).3.5. CcL decreases IL-1β and TNF-α abundance in zymosan-induced TMJ
arthritis in rats
Immunohistochemical analysis showed an increase in TNF-α, IL-1β
and HO-1 expression, which was characterized by brown-colored cells
in the arthritic TMJ of rats injected with zymosan (i.art.), when com-
pared with the sham group (Figs. 6, 7, 8). The sham control group
showed expression of TNF-α, IL-1β and HO-1 only in synovial cells.
The negative control group sections were composed of arthritic TMJs
of rats injected with zymosan that were not treated with anti-TNF-α,
anti-IL-1β or anti-HO-1 antibodies.
A signiﬁcant decrease in TNF-α expression was observed in the
CcL-treated group compared with the zymosan group because the
immunohistochemical analysis did not reveal expression of this
pro-inﬂammatory cytokine in the synovial membrane or in the neutro-
phils. These proﬁles suggest an immunocellular response by CcL during
the acute phase. For IL-1β, there was an intense staining in the synovial
cells and neutrophils in the zymosan group, and this staining was re-
duced in the CcL group, similar to the level of the sham controls. This
basal expression of IL-1β and TNF-α in the sham group may be due to
A B
C
p < 0.001 
p < 0.001 
Fig. 4. Effect of CcL in combinationwith ZnPP-IX onmechanical hyper-nociception (A), leukocyte inﬂux (B) andMPO activity (C) in the rat zymosan (Zy)-induced TMJ arthritis model. Zy
(2mg, 40 μl) or 0.9% salinewas injected i.art. into the left TMJ of the rats. Animals received s.c. saline or CcL (0.1, 1 or 10 mg/kg, i.v.). Data are expressed as themean± S.E.M. of six animals for
each group (ANOVA, Bonferroni's test). ***p b 0.001 indicates a signiﬁcant difference from the sham group. ###p b 0.001 indicates a signiﬁcant difference from the Zy group. +++p b 0.001
indicates a signiﬁcant difference in relation to group ZnPP-IX. + and ++ indicate signiﬁcant difference (p b 0.05 and p b 0.01, respectively) in relation to the ZnPP-IX group.
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showed intense staining for both cytokines from the synovial cells and
neutrophils (Figs. 6, 7).
Finally, immunohistochemical analysis showed intense expression
of HO-1 in synovial cells and neutrophils from the synovial membrane
of rats pretreated with zymosan, and expression of HO-1 in synovial
cells in the CcL group was similar to that of the zymosan group. In addi-
tion, a basal constitutive level of HO-1 in the synovial cells was noted in
the sham group (Fig. 8).
4. Discussion
Previous studies evaluating biopolymers derived from seaweeds
have suggested lectins as research agents that can allow researchers
to comprehensively investigate events related to both nociception
and inﬂammation in animal models [22,23,26,32]. In this work, weTable 2
Histopathological analysis of TMJ on zymosan-induced arthritis: the effect of CcL (10 mg/kg, i.v
Groups Cell inﬂux in the synovial membrane C
Sham 0 (0–0) 0
Zy 4 (3–4)⁎ 4
ZnPP-IX 3 (1–3)⁎ 4
CcL 0 (0–0)⁎⁎ 1
ZnPP-IX + CcL 1 (1–1) 1
0 — uninjured; 1 — low injury; 2 —mild injury; 3 —moderate injury; and 4 — severe injury.
⁎ p b 0.05 versus sham group (Kruskal–Wallis, Dunn's).
⁎⁎ p b 0.05 versus Zy group (Kruskal–Wallis, Dunn's).demonstrated for the ﬁrst time the anti-nociceptive and anti-
inﬂammatory efﬁcacy of C. cupressoides lectin (CcL) in a model of
zymosan-induced TMJ arthritis in rats. Furthermore, we also evaluat-
ed the putative involvement of leukocyte inﬂux, cytokine expression
(IL-1β and TNF-α), the endogenous opioid system and HO-1 path-
ways in CcL efﬁcacy.
Experimental animalmodels of TMJ inﬂammatory hyper-nociception
and arthritis have been proposed for the study of painful inﬂammatory
conditions. Some authors have suggested inducing TMJ arthritis surgical-
ly [33] or mechanically [34], using systemic [35,36], submandibular [37],
or intra-articular (i.art) injections [38].
Recently, our group set up a newmodel of zymosan-induced arthri-
tis in the rat TMJ [1]. In this model, zymosan, a polysaccharide from
yeast cell walls, elicits both hyper-nociception and inﬂammatory
markers including an increase in vascular permeability, edema and
cell migration associated with severe synovitis [39,3]..) in the presence of ZnPP-XI.
ell inﬂux in the periarticular tissue Cell inﬂux in the muscular tissue
(0–0) 0 (0–0)
(3–4)⁎ 2 (2–3)⁎
(2–4)⁎ 2 (1–3)⁎
(1–1)⁎⁎ 0 (0–2)⁎⁎
(1–1)⁎⁎ 2 (0–2)
Fig. 5. Histopathological analysis of zymosan-induced TMJ arthritis in rats. (A) Photomicrographs of TMJ the sham group (40×). (B, C and D) Synovial membrane, periarticular tissue and
musculoskeletal tissue of the sham group without cell inﬂux (400×). (E) Photomicrographs of the TMJ from the Zy group (2 mg/art., 40 μl) (40×). (F, G and H) Synovial membrane,
periarticular tissue and musculoskeletal tissue of the zymosan group with intense cell inﬂux (400×). (I) Photomicrographs of TMJ the ZnPP-IX group (40×). (J, L and M) Synovial mem-
brane periarticular tissue andmusculoskeletal tissue of the group treated ZnPP-IXwith intense cell inﬂux (400×). (N) Photomicrographs of the TMJ following exposure to ZnPP-IX+ CcL
(40×). (O, P and Q) The synovial membrane, periarticular tissue and musculoskeletal tissue of the group treated with ZnPP-IX + CcL with a lower inﬂammatory cell inﬂux (400×). (R)
Photomicrographs of the TMJ from the CcL group (40×). (S, T and U) Synovial membrane, periarticular tissue andmusculoskeletal tissue of the group treated with CcL without cell inﬂux
(400×). C: condyle; AC: articular cartilage; AD: articular disk; SM: synovial membrane; PAT: periarticular tissue; and MET: musculoskeletal tissue. Hematoxylin and eosin staining. Black
arrows indicate neutrophils.
40 R.L. da Conceição Rivanor et al. / International Immunopharmacology 21 (2014) 34–43Using zymosan-induced arthritis in the rat TMJ, some authors have
recently suggested electroacupuncture as an important therapeutic
strategy for treating TMJ arthritis [24]. Although it was demonstrated
that some products derived from seaweeds, such as sulfated polysac-
charides, inhibit the zymosan-induced inﬂammatory response in rats
[17,40], there is no evidence for an effect of lectins.
In the present study, i.art. injection with 2mg of zymosan decreased
the mechanical nociceptive thresholds, which in turn was increased by
CcL treatment. Regarding the inﬂammatory parameters, CcL administra-
tion decreased leukocyte number, which was certiﬁed by a decrease in
MPO activity in the synovial lavage. Furthermore, histopathological
analysis from rat TMJs treated with CcL showed a correlated decrease
in both leukocyte inﬂux andMPO activity, likely because this treatment
produced a lower inﬂammatory cell inﬂux in the synovial membrane.
These data are in accordance with our previous results showing that
CcL has anti-nociceptive and anti-inﬂammatory functions in classical
models of nociception in mice and acute inﬂammation in rats [26].
Additionally, in the present study, histopathological analyses of immu-
nohistochemical stains showed a decrease in both IL-1β and TNF-αexpression in the synovial cells and neutrophils of the zymosan-
induced TMJ inﬂammatory hyper-nociception.
Cytokines are produced by various cell types in response to a variety
of stimuli and constitute a link between cellular injury or recognition of
non-self and the development of signs and symptoms of inﬂammation
[41,42]. Intra-plantar injection of both TNF-α and IL-1β induced
hyper-nociception in mice [43]. Furthermore, writhing responses to
zymosan and acetic acid were shown to be mediated by TNF-α and IL-
1β [44]. Moreover, in mechanical (von Frey ﬁlaments) and thermal
(hot plate) hyper-nociception induced by complete Freund's adjuvant,
there was a sequential release of TNF-α and IL-1β [45,46].
It was also revealed that TNF-α activates IL-1β, leading to the induc-
tion of connective tissue disorders in chronic inﬂammatory condi-
tions [47], and TNF-α was addressed as a biochemical marker of pain
and clinical outcome in temporomandibular joints [48,49]. The resolu-
tion of the inﬂammatory response during arthritis might be attributed
to the inhibition of pro-inﬂammatory cytokines, such IL-1β and TNF-
α. These two factors are assumed to be the most important cytokines
in TMJ disorders [5,47]. In fact, it seems that these cytokines induce
Fig. 6. Immunohistochemistry analysis for TNF-α of zymosan-induced TMJ arthritis in rats. (A) Negative control sections (absence of anti- TNF-α antibody) from arthritic rats (400×).
(B) The synovial membrane from the sham group showed light expression of TNF-α. (C) The synovial membrane from the zymosan group (2 mg/art.) with an intense TNF-α reaction
(400×). (D) CcL (10 mg/kg, i.v.) showing no TNF-α reaction in the synovial membrane after zymosan-induced arthritis (400×). Black arrows indicate synoviocytes.
41R.L. da Conceição Rivanor et al. / International Immunopharmacology 21 (2014) 34–43the production of metalloproteinases that irreversibly degrade the
extracellular matrix components [5], including articular cartilage, as
well as causing bone destruction and cell proliferation [50]. Taken to-
gether, these experiments strongly suggest that the release of cytokines
constitutes a link between the TMJ injuries and the release of primaryFig. 7. Immunohistochemistry analysis for IL-1β of zymosan-induced TMJ arthritis in rats. (A) N
(B) The synovial membrane of the sham group revealed light expression of IL-1β (400×). (C)
(400×). (D) CcL (10 mg/kg, i.v.) showing no expression of IL-1β in the synovial membrane afthyper-nociceptive mediators. This concept allows us to understand
why the inhibition of cytokines causes analgesia [51].
According to Gondim et al. [24], electroacupuncture inhibited
zymosan-induced TMJ inﬂammatory hyper-nociception, as well as neu-
trophil migration, vascular permeability, and TNF-α levels in synovialegative control sections (absence of the anti- IL-1β antibody) from arthritic rats (400×).
The synovial membrane of the zymosan group (2 mg/art.) with an intense IL-1β reaction
er zymosan-induced arthritis (400×). Black arrows indicate synoviocytes.
Fig. 8. Immunohistochemistry analysis for HO-1 in zymosan-induced TMJ arthritis in rats. (A) Negative control sections (absence of the anti- HO-1 antibody) from arthritic rats (400×).
(B) Synovialmembrane from the shamgroup revealed the basal constitutive levels of HO-1 (400×). (C) Synovialmembrane of the zymosan group (2 mg/art.), intense expression of HO-1
(400×). (D) CcL (10 mg/kg, i.v.) showing no expression of HO-1 in the synovial membrane after zymosan-induced arthritis (400×). Black arrows indicate synoviocytes.
42 R.L. da Conceição Rivanor et al. / International Immunopharmacology 21 (2014) 34–43ﬂuid. Additionally, Paiva et al. [17] showed that sulfated polysaccharides
from the brown Lobophora variegata decreased both cell inﬂux and TNF-
α expression in knee joints.
Because it has been largely demonstrated that cytokines play an
important role in inﬂammatory hyper-nociception, our results sug-
gested that CcL efﬁcacy in zymosan-induced TMJ inﬂammatory
hyper-nociception might be related, at least in part, to IL-1β and
TNF-α inhibition.
The endogenous opioid system is largely involved in the phenome-
non of the experience of pain [10], as well as in the action of analgesic
opiate compounds [18]. In the TMJ, a role of the peripheral opioid recep-
tors in the TMJ anti-nociception has been established [11,12]. In the
present study, the antinociceptive response of the lectin C. cupressoides
was not reversed by i.art. injection of naloxone, a nonselective opioid
receptor antagonist, in this experimental model, although it was capable
of reversing the effects of morphine. This result suggests that endoge-
nous opioids do not mediate the antinociceptive effect of CcL, which
modulates TMJ nociception at the peripheral level, but CcL does not act
through peripheral opioid receptors. The possibility that the lectin
C. cupressoides can exert its antinociceptive effects through central
involvement of opioid receptors has not been excluded. However,
Vanderlei et al. [26] demonstrated that the antinociceptive response
of CcL, using classical models of nociception (formalin and hot-
plate tests) in mice, occurred predominantly through a peripheral
mechanism.
HO-1 is a relevant target for discovering compounds exhibiting
antinociceptive [8] and anti-inﬂammatory [9] mechanisms. Agents
that elicit HO-1 also have great therapeutic importance against diseases
associated with inﬂammatory processes. HO-1 expression may reduce
edema, leukocyte adhesion, migration and the production of cytokines
[52]. Vicente et al. [50] reported the induction of HO-1 in a zymosan-
induced air pouch inﬂammation model. In the present study, the pre-
treatment of animals with ZnPP-IX, a speciﬁc HO-1 inhibitor, decreased
the nociceptive thresholds. However, analgesic and anti-inﬂammatoryeffects of CcL (10 mg/kg, i.v.) were observed in the presence of ZnPP
IX, suggesting that the HO-1 pathway is not required for CcL efﬁcacy.
In conclusion, we demonstrated the anti-nociceptive and anti-
inﬂammatory efﬁcacy of CcL in a model of zymosan-induced TMJ in-
ﬂammatory hyper-nociception in rats. Additionally, our results strongly
suggest that CcL efﬁcacy involves IL-1β and TNF-α inhibition. Given the
well-demonstrated anti-nociceptive and anti-inﬂammatory efﬁcacy of
CcL, the design of novel compounds is highly encouraged with the
hope of deﬁning new pharmacological targets for the treatment of
inﬂammatory TMJ pain.Acknowledgments
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